Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion type Assertion NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_head.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion description "[* However, the observed variability of the platelet response to the cyclooxygenase inhibitor acetylsalicylic acid (in our study) and to the P2Y(12) ADP receptor blocker clopidogrel (in a study by Angiolillo et al) in patients with coronary artery disease is clearly not determined by common P2Y(12) ADP receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_provenance.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion evidence source_evidence_literature NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_provenance.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion SIO_000772 17995973 NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_provenance.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion wasDerivedFrom befree-20150227 NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_provenance.
- NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_assertion wasGeneratedBy ECO_0000203 NP867590.RATVxbzyA8YqnV8zh65Btnh-JezhAf3km5PWPi02gfWK8130_provenance.